JUST, Inc.: Clean Meat and the Future of Protein Alternatives

Discussion Guide and Teaching Notes

Today’s Agenda

  1. Case Discussion: Collins-Carey et al. (2020), JUST, Inc.: Clean Meat and the Future of Protein Alternatives — led by Team F.
  2. Focus on the strategic choice among four paths:
    • Enter clean meat (cultured meat)
    • Enter plant-based meat
    • Enter edible insects
    • Double down on plant-based alternatives (status quo/core)
  3. Connect to this week’s concepts: industry life cycles, dominant design, go-to-market, and mission–strategy fit.

Key Terms: Alternative Protein Landscape

  • Clean (Cultured) Meat – Animal cells grown in bioreactors to form edible muscle tissue.
  • Plant-Based Meat – Texture/flavor engineered from plant proteins (e.g., soy, pea, wheat).
  • Plant-Based Alternatives – Non-meat analogs (e.g., JUST Egg, mayo, dressings).
  • Edible Insects – Protein from insects (e.g., crickets) whole or as ingredients (flour).
  • Dominant Design – A prevailing product architecture that shapes competition.
  • First-Mover Advantage – Benefits from early market entry before standards/leaders emerge.

Role Play: You Are Josh Tetrick (CEO)

  • Mission-driven founder with prior wins (JUST Egg) and a controversial history that raises reputational/regulatory risk.
  • Decision (2017): Where should JUST invest next to lead the protein transition?
  • Constraints: capital intensity (esp. clean meat), regulatory uncertainty, consumer acceptance, and competition.

Prompt

From the CEO seat: What path best advances impact + viability while leveraging JUST’s algorithm/R&D and brand?

JUST at a Glance (Timeline)

Year Milestone Why It Matters
2011–2016 Founding (as Hampton Creek), plant-based R&D & product launches Built brand + discovery algorithm
2017 Rebrand to JUST, Inc.; consider new protein categories Strategic fork in the road
2018–2019 JUST Egg scales; Minnesota facility enables 24/7 mung-protein extraction Demonstrates ops scaling in core
2018–2020 Accel in clean meat R&D across industry (e.g., Memphis Meats, Aleph) Competitive race; rising capital needs

Learning Objectives (for Students)

  • Evaluate market attractiveness across clean meat, plant-based meat, insects, and core plant-based alternatives.
  • Assess fit with JUST’s resources/capabilities and mission alignment.
  • Anticipate go-to-market hurdles: regulation, cost curves, consumer adoption, supply chains.

Market Snapshots

Clean Meat

  • Pros: Potential parity on taste/texture; large long-run TAM; ethical/land/water upside.
  • Cons: High capex + R&D risk; regulation & labeling; consumer “lab-grown” skepticism; energy intensity.

Plant-Based Meat

  • Pros: Momentum + near-term growth; access to flexitarians; leverages JUST’s discovery platform.
  • Cons: Strong incumbents (Beyond, Impossible); taste/texture arms race; late-mover risks.

Plant-Based Alternatives (Core)

  • Pros: Brand equity; proven ops scaling (JUST Egg); lower regulatory friction.
  • Cons: Finite substitution space; supply chain build-outs for novel inputs; slower path to category leadership.

Edible Insects

  • Pros: Efficient feed conversion; niche demand growth; ingredient versatility.
  • Cons: Cultural barriers in U.S.; fragmented field; far from JUST’s capabilities/brand.

Industry Life Cycle & Design

  • Where are categories on the curve?
    • Clean meat: emergent / pre-dominant design
    • Plant-based meat: growth / design converging
    • Plant-based alternatives: growth / fragmentation by application
    • Insects: emergent / niche

Discussion Prompt

If dominant design emerges in clean meat in 3–5 years, does JUST want to shape it or adapt to it?

The Strategic Choice

Options:

  1. Enter Clean Meat (pursue first-mover potential)
  2. Enter Plant-Based Meat (fast-follower vs. incumbents)
  3. Enter Edible Insects (ingredient play, niche)
  4. Double Down on Core (expand plant-based alternatives portfolio)

Regulatory Pathways (FDA/USDA)

Cultured meat (clean meat)

  • Pre-market consultations, facility registration, inspections
  • Joint FDA–USDA oversight (cells → FDA; harvest/processing → USDA)
  • Labeling and nomenclature uncertainty

Plant-based

  • FDA food rules (ingredients, allergens, GRAS, labeling)
  • Claims (protein quality, sustainability) need substantiation

Implication for JUST

  • Clean meat: longer, costlier path; high policy risk
  • Plant-based: clearer path; faster channel expansion

Prompt: If the dominant design in cultured meat is 3–5 years out, does JUST want to shape it or follow it?

Food Safety, GMP, and Liability

  • GMP is non-negotiable for national retail
  • Traceability: one-step forward/back, batch IDs, recall readiness
  • Risk: contamination, allergen control, supply chain failures

JUST Application

  • Clean meat: aseptic bioprocessing, media control, QA/QC uptick
  • Plant-based: co-manufacturing + supplier audits; simpler—but still strict

Quick Check: What documentation must JUST have in place before pitching a national QSR pilot?

Contracts & Channel Access

  • Brokers/Distributors: unlock retail buyers but take margin
  • Slotting/Promotion: trade spend planning matters
  • Co-packing: capacity, MOQs, lead times, quality specs, IP/NDAs
  • Force majeure: supply shocks, logistics, recalls

JUST Application

  • Core/plant-based: leverage co-packers to scale JUST Egg–adjacent lines
  • Clean meat: likely JV/strategics for pilot plants + foodservice entry

Exercise: Draft 3 must-have contract clauses JUST should demand from a co-packer for a new plant-based SKU.

Cottage Food vs. Commercial Reality

  • Cottage laws ≠ wholesale/interstate
  • National brands require commercial facilities + audits (GMP/HACCP)

JUST Application

  • All four paths require commercial compliance; no cottage shortcuts
  • Clean meat adds bioprocess validation and new SOPs

Market Access & Competition

Barriers

  • Shelf space (category captaincy by incumbents)
  • Velocity expectations, cold chain, slotting fees
  • Consumer acceptance (taste, texture, name)

Playbooks

  • Plant-based: fast-follower differentiation (protein source, nutrition, price)
  • Clean meat: staged foodservice launches; transparent messaging
  • Core: deepen penetration (foodservice + retail), capacity expansion

Think: What is JUST’s “Haribo focus”? (One killer SKU or platform where it can dominate.)

Costs, Pricing, and Thin Margins

  • Rising inputs, labor, freight, trade spend → squeeze gross margin
  • Clean meat: Very high capex/opex until media yield improves
  • Plant-based/core: scale lowers COGS; ingredient hedging helps

Decision Lens

  • Can JUST hit a price-to-value that drives velocity without burning runway?

Compare the Paths

Path Strategic Fit Capital Need Regulatory Risk Consumer Adoption Speed to Revenue
Clean Meat High (mission) / Medium (capabilities) Very High High Medium (omnivores) Low
Plant-Based Meat High High Medium Medium–High Medium
Core Alternatives Very High Medium Low High (existing) High
Insects Low Medium Medium Low–Medium (U.S.) Low

Finance & Ops Implications

  • Clean Meat: Bioreactors, cell lines, scaffolding, media costs, QA; multi-year burn to unit economics.
  • Plant-Based Meat: Ingredient supply (pea/soy/wheat proteins), extrusion tech, flavor science.
  • Core: Capacity expansions, channel partnerships (retail/foodservice), brand building.
  • Insects: Farming or sourcing, processing to ingredients, B2B demand development.

Class Exercise (Investor Lens)

You’re an investor hearing JUST’s pitch for one path.

  1. What traction or technical milestones must you see?
  2. What are the leading risks and how are they mitigated?
  3. What terms/structure (e.g., staged capital, milestones) would you require?

Discussion Questions

  1. Which path best aligns with JUST’s mission–market–means triangle?
  2. How should prior reputational turbulence shape entry timing/communications?
  3. Where can JUST’s algorithmic discovery create durable edge?
  4. What sequencing option (now vs. later) best balances risk and upside?
  5. If entering clean meat, what partnerships (bioprocess, regulatory, distribution) are pivotal?

Scorecard Exercise

Option Capability Fit (1–5) Market Attractiveness (1–5) Risk (1–5, low=5) Mission Alignment (1–5) Total
Clean Meat ___ ___ ___ ___ ___
Plant-Based Meat ___ ___ ___ ___ ___
Core Alternatives ___ ___ ___ ___ ___
Insects ___ ___ ___ ___ ___

Write 3–4 sentences defending your recommendation and proposed next steps.

Go-to-Market: If Clean Meat Wins

  • Milestones: cost curve (media ↓, yield ↑), sensory parity, regulatory pathway, pilot plant.
  • Allies: academic labs, bioprocess OEMs, strategic CPG/meat partners, advocacy orgs.
  • GTMP: limited-scope launches (foodservice), transparent messaging, data on safety & sustainability.

Go-to-Market: If Plant-Based Meat Wins

  • Differentiate: novel proteins via discovery platform; superior nutrition or price.
  • Ops: co-manu vs. owned lines; secure inputs; flavor/texture IP.
  • Channels: QSR pilots → retail; chef partnerships; retailer category captaincy.

Epilogue (for Debrief)

  • JUST ultimately pursues clean meat while scaling JUST Egg; costs decline but commercialization remains staged; competitive field intensifies.
  • Debrief: Was this optimal sequencing given capabilities, risk, and the market window? What would you do in 2026?

Key Takeaways

  • Fit before flash: Match path to capabilities, mission, and runway.
  • Design & timing matter: Pre-dominant-design races reward crisp milestones and alliances.
  • De-risk in stages: Sequence bets; protect the core while advancing the frontier.
  • Narrative discipline: Reg- and reputation-aware communications are strategic assets.